We report herein the development, synthesis, physicochemical and pharmacological characterization of a novel class of pharmacodynamic hybrids that selectively inhibit cyclooxygenase-2 (COX-2) isoform and present suitable nitric oxide releasing properties. The replacement of the ester moiety with the amide group gave access to in vivo more stable and active derivatives that highlighted outstanding pharmacological properties. In particular, the glycine derivative proved to be extremely active in suppressing hyperalgesia and edema.
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors / Biava, M; Battilocchio, C; Poce, G; Alfonso, S; Consalvi, S; Di Capua, A; Calderone, V; Martelli, A; Testai, L; Sautebin, Lidia; Rossi, Antonietta; Ghelardini, C; Di Cesare Mannelli, L; Giordani, A; Persiani, S; Colovic, M; Dovizio, M; Patrignani, P; Anzini, M.. - In: BIOORGANIC & MEDICINAL CHEMISTRY. - ISSN 0968-0896. - 22:2(2014), pp. 772-786. [10.1016/j.bmc.2013.12.008]
Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.
SAUTEBIN, LIDIA;ROSSI, ANTONIETTA;
2014
Abstract
We report herein the development, synthesis, physicochemical and pharmacological characterization of a novel class of pharmacodynamic hybrids that selectively inhibit cyclooxygenase-2 (COX-2) isoform and present suitable nitric oxide releasing properties. The replacement of the ester moiety with the amide group gave access to in vivo more stable and active derivatives that highlighted outstanding pharmacological properties. In particular, the glycine derivative proved to be extremely active in suppressing hyperalgesia and edema.| File | Dimensione | Formato | |
|---|---|---|---|
|
Biava, 2014.pdf
accesso aperto
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
1.39 MB
Formato
Adobe PDF
|
1.39 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
